Publications by authors named "Henry Hsu"

Claim this Profile
I
Implementation of bedside handover that includes patients or carers in hospital settings: A systematic review.
Amy Maher, Henry Hsu, Mohamed Eftal Bin Mohamed Ebrahim, Matthew Vukasovic, Andrew Coggins

J Eval Clin Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin-receptor agonism prevents right ventricular tissue pathology in a mouse model of Duchenne muscular dystrophy.
Shivam Gandhi, Luca J Delfinis, Parashar D Bhatt, Madison C Garibotti, Catherine A Bellissimo, Henry H Hsu

Mol Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation (V-A ECMO): A systematic review and meta-analysis.
Henry R Hsu, Praba Sekhar, Jahnavi Grover, David H Tian, Ciaran Downey

PLoS One· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Joe S Mendez, Adam L Cohen, Midori Eckenstein, Randy L Jensen, Lindsay M Burt, Henry H Hsu

Neurooncol Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a non-invasive bioassay for adiponectin target engagement in mice.
Jialing Tang, Yubin Lei, Angelica Pignalosa, Henry H Hsu, Ali A Abdul-Sater

iScience· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis.
Zhe Huang, Hye Kyoung Sung, Xingqun Yan, Shiyu He, Leigang Jin, Henry H Hsu

Clin Transl Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel blood-based bioassay to monitor adiponectin signaling.
Abdul Hadee Lone, Jialing Tang, Angelica Pignalosa, Henry H Hsu, Ali A Abdul-Sater

Int Immunopharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2. mouse model of Duchenne muscular dystrophy.
Catherine A Bellissimo, Shivam Gandhi, Laura N Castellani, Mayoorey Murugathasan, Luca J Delfinis, Henry H Hsu

Am J Physiol Cell Physiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF).
Sungji Cho, Keith Dadson, Hye Kyoung Sung, Oyeronke Ayansola, Ali Mirzaesmaeili, Henry H Hsu

Biomed Pharmacother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expedited transport versus continued on-scene resuscitation for refractory out-of-hospital cardiac arrest: A systematic review and meta-analysis.
Brian Burns, Henry R Hsu, Anthony Keech, Yating Huang, David H Tian

Resusc Plus· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ⅰ/Ⅱ, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension.
Paul J Hartman, David L Cooke, Henry H Hsu, Jeanette Stewart, Kengo Sumi

Ophthalmol Glaucoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Charles Peterfy, Yan Chen, Peter Countryman, Bartosz Chmielowski, Stephen P Anthony, Henry H Hsu

Future Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.
William D Tap, Arun S Singh, Stephen Patrick Anthony, Mike Sterba, Chao Zhang, Henry H Hsu

Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.
Catherine C Smith, Aaron D Viny, Evan Massi, Cyriac Kandoth, Nicholas D Socci, Henry H Hsu

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.
Hans Gelderblom, Andrew J Wagner, William D Tap, Emanuela Palmerini, Zev A Wainberg, Henry H Hsu

Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ridge Augmentation Comparing a Cancellous Block Allograft to an Osteoinductive Demineralized Bone Matrix Allograft: A Randomized, Controlled, Blinded Clinical Trial.
Bobby Lee Cockerham, Abhishek Patel, Henry Greenwell, Margaret Hill, Brian Shumway, Henry T Hsu

Int J Periodontics Restorative Dent· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia.
Catherine C Smith, Mark J Levis, Olga Frankfurt, John M Pagel, Gail J Roboz, Henry H Hsu

Blood Adv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Effect of Topical Adiponectin-Derived Short Peptides Compared with Globular Adiponectin in Experimental Dry Eye and Alkali Burn.
Ying Li, Rujun Jin, Lan Li, Henry H Hsu, In Cheon You

J Ocul Pharmacol Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.
William D Tap, Hans Gelderblom, Emanuela Palmerini, Jayesh Desai, Sebastian Bauer, Henry H Hsu

Lancet· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS).
Heather L Gelhorn, Xin Ye, Rebecca M Speck, Sandra Tong, John H Healey, Henry H Hsu

J Patient Rep Outcomes· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and benefits of computerized cognitive exercise to adults with chronic moderate-to-severe cognitive impairments following an acquired brain injury: A pilot study.
Therese M O'Neil-Pirozzi, Henry Hsu

Brain Inj· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
Nicholas Butowski, Howard Colman, John F De Groot, Antonio M Omuro, Lakshmi Nayak, Henry H Hsu

Neuro Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Heather L Gelhorn, Sandra Tong, Kelly McQuarrie, Christina Vernon, Jennifer Hanlon, Henry H Hsu

Clin Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
William D Tap, Zev A Wainberg, Stephen P Anthony, Prabha N Ibrahim, Chao Zhang, Henry H Hsu

N Engl J Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397.
Catherine C Smith, Chao Zhang, Kimberly C Lin, Elisabeth A Lasater, Ying Zhang, Henry H Hsu

Cancer Discov· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis